73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Researchers study how altered protein degradation contributes to the development of tumors

Researchers study how altered protein degradation contributes to the development of tumors

by Institute for Research in Biomedicine (IRB Barcelona)To ensure adequate levels of proteins in the cell, a strict quality control system is responsible for tagging the proteins with ubiquitin f

Researchers study how altered protein degradation contributes to the development of tumors

by Institute for Research in Biomedicine (IRB Barcelona)To ensure adequate levels of proteins in the cell, a strict quality control system is responsible for tagging the proteins with ubiquitin f
Loss of Y chromosome in men enables cancer to grow, finds new study

Loss of Y chromosome in men enables cancer to grow, finds new study

by Cedars-Sinai Medical CenterCredit: Pixabay/CC0 Public DomainAs men age, some of their cells lose the very thing that makes them biological males—the Y chromosome—and this loss hampers the body

Loss of Y chromosome in men enables cancer to grow, finds new study

by Cedars-Sinai Medical CenterCredit: Pixabay/CC0 Public DomainAs men age, some of their cells lose the very thing that makes them biological males—the Y chromosome—and this loss hampers the body
High levels of depression found among Canadian older adults with cancer during the COVID-19 pandemic

High levels of depression found among Canadian older adults with cancer during the COVID-19 pandemic

by University of TorontoCredit: Unsplash/CC0 Public DomainOlder adults who have had cancer had a high risk of experiencing symptoms of depression during the early months of the COVID-19 pandemic

High levels of depression found among Canadian older adults with cancer during the COVID-19 pandemic

by University of TorontoCredit: Unsplash/CC0 Public DomainOlder adults who have had cancer had a high risk of experiencing symptoms of depression during the early months of the COVID-19 pandemic
Taming overactive molecular signaling in renal cell cancer

Taming overactive molecular signaling in renal cell cancer

by Johns Hopkins University School of MedicineMurine renal tumors with Tsc2 loss have increased TFEB/TFE3 nuclear localization. Credit: Clarence Rachel Villanueva and Adrianna A. Mendes,Nat

Taming overactive molecular signaling in renal cell cancer

by Johns Hopkins University School of MedicineMurine renal tumors with Tsc2 loss have increased TFEB/TFE3 nuclear localization. Credit: Clarence Rachel Villanueva and Adrianna A. Mendes,Nat
Researchers shed light on signaling pathway responsible for head and neck cancers

Researchers shed light on signaling pathway responsible for head and neck cancers

by Gina DiGravio,Boston University School of MedicineCausal Inference Models of Interactions Between Pathways/Cell States in Head and Neck Cancer scRNAseq Data. A. Causal inference graphs indica

Researchers shed light on signaling pathway responsible for head and neck cancers

by Gina DiGravio,Boston University School of MedicineCausal Inference Models of Interactions Between Pathways/Cell States in Head and Neck Cancer scRNAseq Data. A. Causal inference graphs indica
Researchers discover method to 'turn off' mutated melanoma

Researchers discover method to 'turn off' mutated melanoma

by Boston University School of MedicineMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Melanoma is the deadliest f

Researchers discover method to 'turn off' mutated melanoma

by Boston University School of MedicineMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Melanoma is the deadliest f
Researchers identify key metabolic regulators of drug resistance in the fight against pancreatic cancer

Researchers identify key metabolic regulators of drug resistance in the fight against pancreatic cancer

by Rebecca Brierley,University at BuffaloGraphical abstract. Credit:Molecular & Cellular Proteomics(2022). DOI: 10.1016/j.mcpro.2022.100409Researchers from the University at Buff

Researchers identify key metabolic regulators of drug resistance in the fight against pancreatic cancer

by Rebecca Brierley,University at BuffaloGraphical abstract. Credit:Molecular & Cellular Proteomics(2022). DOI: 10.1016/j.mcpro.2022.100409Researchers from the University at Buff
Race/ethnicity, socioeconomics, age contribute to disparities in cancer death

Race/ethnicity, socioeconomics, age contribute to disparities in cancer death

by Elana GotkineFactors contributing to disparities in cancer death include race/ethnicity, socioeconomic status, geographic location, and age, according to a study published online Nov. 14 inCA

Race/ethnicity, socioeconomics, age contribute to disparities in cancer death

by Elana GotkineFactors contributing to disparities in cancer death include race/ethnicity, socioeconomic status, geographic location, and age, according to a study published online Nov. 14 inCA
Researchers suggest new way to target third most common oncogene, TERT

Researchers suggest new way to target third most common oncogene, TERT

by Garth Sundem,CU Anschutz Medical CampusChromosome, showing telomeres in pink. Credit: CUHealthy cells have a built-in self-destruct mechanism: Strands of DNA called "telomeres" act

Researchers suggest new way to target third most common oncogene, TERT

by Garth Sundem,CU Anschutz Medical CampusChromosome, showing telomeres in pink. Credit: CUHealthy cells have a built-in self-destruct mechanism: Strands of DNA called "telomeres" act
Study reveals pathways for aggressive prostate cancer subtype

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati
Team finds key to common cancer pathway

Team finds key to common cancer pathway

by Terry Devitt,University of Wisconsin-MadisonThe molecular pathway for the protein p53, commonly associated with many cancers, is illuminated in this micrograph. The p53 - PIP2 complex is show

Team finds key to common cancer pathway

by Terry Devitt,University of Wisconsin-MadisonThe molecular pathway for the protein p53, commonly associated with many cancers, is illuminated in this micrograph. The p53 - PIP2 complex is show
Allogeneic hematopoietic cell transplant outcomes improved from 2005 to 2019: Study

Allogeneic hematopoietic cell transplant outcomes improved from 2005 to 2019: Study

by Lori SolomonOutcomes of allogeneic hematopoietic cell transplantation (allo-HCT) in patients with acute myeloid leukemia (AML) and second complete remission (CR2) have significantly improved over t

Allogeneic hematopoietic cell transplant outcomes improved from 2005 to 2019: Study

by Lori SolomonOutcomes of allogeneic hematopoietic cell transplantation (allo-HCT) in patients with acute myeloid leukemia (AML) and second complete remission (CR2) have significantly improved over t